Yujie Zhou, Professor

chief physician, professor, doctoral supervisor, competent person of postdoctoral station, national major clinical discipline leader, secretary general of Chinese Society of Cardiology, deputy director member of Committee of Cardio-cerebral-vascular Disease, Gerontology Society of China, director member of Expert Committee of China Society for the Promotion of International Exchange, deputy director member of Committee of Cardiovascular Diseases of China Elder Health Care Association, deputy director member of Beijing Commission of Chronic Disease Management, deputy director member of Beijing Cardiovascular Working Commission of Chinese Medical Association, director member of Grassroots Working Committee of Chinese Medical Doctor Association, director member of Cardiovascular Commission of Chinese Medical Doctor Association, and diagnosis expert of Central Healthcare Commission, president of Journal of Heart, Lung and Blood Vessel Diseases, editorial board member of Chinese Medical Journal and other medical publications, good at sophisticated, highly difficult and high-risk percutaneous coronary interventional therapy and emergency treatment of critical cardiovascular diseases, winner of Leading Talent in Beijing Health System, Outstanding Health Science and Technology Talent, New Century Ten, Hundred and Thousand Outstanding Talent and Young and Middle-Aged Expert with Outstanding Contributions, concurrently acting as senior members of FACC, FHRS, FSCAI and FESC of International Society of Cardiovascular Diseases.

Research Interests: Clinical treatment and basic research of cardiovascular diseases.

Principal Investigator

· “Effect of kruppel-like factor 2 transcription factor in endothelial dysfunction induced by rapamycin”. Funded by the National Natural Science Foundation of China. Support period: 01/2010–12/2012.

· “Effect and mechanism of endoplasmic reticulum stress induced by angiotensin II on contrast-induced renal tubular cell apoptosis”. Funded by the National Natural Science Foundation of China. Support period: 01/2013–12/2016.

Participating Investigator

· Directed sub-project “Study on the technique system of early diagnosis and treatment of coronary heart disease”. Funded by the Eleventh Five-Year National Science and Technology Support Program.

SCI papers published in the past five years:

1. Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Int J Cardiol. 2011 (148):96-101.(IF 7.078)

2. Liu W, Zhou YJ*, Liu YY, Shi DM.Is this spontaneous coronary intramural hematoma or fibrotic plaque?: an inconsistent finding between optical coherent tomography and intravascular ultrasound. JACC Cardiovascular Intervention. 2013 Sep;6(9):983-4.(IF 6.55)

3. Yang SW, Zhou YJ*, Tian XF, Pan GZ, Liu YY, Zhang J, Guo ZF, Chen SY, Gao ST, Du J, Jia DA, Fang Z, Hu B, Han HY, Gao F, Hu DY, Xu YY; Beijing Heart and Metabolism Survey Study Group.Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease. Mayo Clin Proc.2013 Sep;88(9):930-41.(IF 5.79)

Address：E-mail：azzyj12@163.com Tel：010-64456489